Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
18.30M
Fund Score
Tema Oncology ETF (NASDAQ:CANC) Quotes, Forecast and News Summary
Tema Oncology ETF (NASDAQ: CANC) stock price, news, charts, stock research, profile.
| Open | $25.31 |
| High | $25.31 |
| 52 Wk High | $30.11 |
| AUM | 18.30M |
| Dividend | $0.13 |
| Ex-Div Date | Dec 13, 2023 |
| Volume | 13.69K |
| Market Cap | $46.54B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 26.82 |
| Prev. Close | $25.16 |
| Low | $25.11 |
| 52 Wk Low | $23.97 |
| Shares Out | 680.00K |
| Yield | 0.48% |
| Div. Freq | U |
| Avg. Volume Daily | 7.56K |
| Beta | 1.22 |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 3.53 |
Recent News
FAQ
Q
How do I buy Tema Oncology ETF (CANC) stock?
A
You can purchase shares of Tema Oncology ETF (NASDAQ:CANC) through any online brokerage.
Q
Who are Tema Oncology ETF (CANC) competitors?
A
There are no as such competitors for Tema Oncology ETF.
Q
What is the forecast, or price target, for Tema Oncology ETF (CANC) stock?
A
There is no analysis for Tema Oncology ETF to provide a consensus price target.
Q
What is the current price for Tema Oncology ETF (CANC)?
A
The stock price for Tema Oncology ETF (NASDAQ: CANC) is $24.99 last updated December 26, 2024 at 9:19 AM EST.
Q
Does Tema Oncology ETF (CANC) pay a dividend?
A
There are no upcoming dividends for Tema Oncology ETF.
Q
When is Tema Oncology ETF (NASDAQ:CANC) reporting earnings?
A
Tema Oncology ETF does not have any upcoming earnings scheduled.
Q
Is Tema Oncology ETF (CANC) going to split?
A
There is no upcoming split for Tema Oncology ETF.
| Open | $25.31 |
| High | $25.31 |
| 52 Wk High | $30.11 |
| AUM | 18.30M |
| Dividend | $0.13 |
| Ex-Div Date | Dec 13, 2023 |
| Volume | 13.69K |
| Market Cap | $46.54B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 26.82 |
| Prev. Close | $25.16 |
| Low | $25.11 |
| 52 Wk Low | $23.97 |
| Shares Out | 680.00K |
| Yield | 0.48% |
| Div. Freq | U |
| Avg. Volume Daily | 7.56K |
| Beta | 1.22 |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 3.53 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Aug 15, 2023 |
| Managers | David Song Maurits Pot Ryan Houlton Troy Cates Garrett Paolella Yuri Khodjamirian |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Tema Oncology ETF actively invests in oncology companies for long-term growth. It focuses on firms providing breakthrough solutions in cancer diagnosis, treatment, and healthcare services, including pharmaceuticals, diagnostic companies, medical device manufacturers, and healthcare providers.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| REGN | Regeneron Pharmaceutic... | 5.87% |
| LN | Astrazeneca Plc | 5.52% |
| MRK | Merck & Co Inc - Commo... | 4.77% |
| JP | Daiichi Sankyo Co Ltd | 3.94% |
| AS | Argenx Se Spon Adr Eac... | 3.64% |
| AMGN | Amgen Inc. | 3.39% |
| BPMC | Blueprint Medicines Co... | 3.38% |
| NTLA | Intellia Therapeutics ... | 3.16% |
| EXEL | Exelixis Inc | 3.16% |
| INCY | Incyte Corp. | 3.03% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved